Survodutide ki a Tirzepatide: Me pēhea te whakarite?

Ko te Survodutide me te tirzepatide he rongoā werohanga e rangahaua ana mo te whakaheke taumaha me te hauora metabolic. Ko te rereketanga nui ko te tirzepatide kua whakaaetia e te FDA, ka kitea whānuitia, ko te survodutide kei roto tonu i ngā whakamātau haumanu, ā, kāore anō kia kitea e te marea. Ka mahi hoki mā ngā ara homoni rerekē, ā, ka whai take pea mō ngā whāinga hauora motuhake.

Mēnā kei te ngana koe ki te mārama me pēhea te whakarite o ēnei rongoā e rua, koinei ngā rangahau e whakaatu ana i tēnei wā.

Me pēhea te mahi o ia rongoā?

He kaikōwhai takirua ngā rongoā e rua, arā, ka whakahohehia e rāua ngā kaiwhiwhi homoni e rua i te wā kotahi. Engari ko ngā takirua kaiwhiwhi e whaia ana e rāua he rerekē, ā, ka whakarerekē tōna pānga ki tō tinana.

Tirzepatide ka whai i ngā kaiwhiwhi GLP-1 me GIP. Ko te GLP-1 (glucagon-like peptide-1) ka whakaiti i te hiahia kai, ka āta whakaiti i te putanga o te kopu, ā, ka āwhina i te whakahaere i te huka toto. Ko te GIP (glucose dependent insulinotropic polypeptide) ka whakanui ake te whakaputanga o te insulin, ā, ka whai mana pea ki te āhua o te rongoā o tō tinana ki te ngako. Tahi, ko ēnei ara e rua ka hua mai he tino pānga ki te whakahaere huka toto me te whakaheke taumaha. Ka hokona te tirzepatide i raro i ngā ingoa waitohu Mounjaro (mō te mate huka momo 2) me Zepbound (mō te whakahaere taumaha).

Survodutide ka whai i ngā kaiwhiwhi GLP-1 me te glucagon. Ka tohaina e ia te mahi GLP-1 e whakaiti ana i te hiahia kai ki te tirzepatide, engari hei utu mō te GIP, ka whakahohehia e ia te ara glucagon. Ka āwhina te Glucagon ki tō tinana kia piki ake te whakapau kaha me te tahu ngako kua rongoa, ina koa te ngako o te ate. Ka waiho tēnei hei survodutide hei tino whai take mō ngā mate pēnei i te MASH (metabolic dysfunction-associated steatohepatitis), he momo mate ate ngako kino.

Nō reira ko te tirzepatide ka aro ki te hiahia kai me te tohu insulin, ko te survodutide ka aro ki te hiahia kai me te whakapau kaha. Ka hua nei te whakaheke taumaha, engari mā ngā tikanga rerekē.

He aha te korero a ngā raraunga whakaheke taumaha?

Koinei te wāhi e hiahia ana te nuinga ki tētahi whakautu mārama. I runga i ngā raraunga whakamātau haumanu e wātea ana, kei te whakaatu te tirzepatide i tētahi nui ake o ngā hua whakaheke taumaha i te survodutide.

Ko tētahi rangahau nui o te tau 2022 me ngā kaiuru 2,539 i kitea ai ko te tirzepatide i ngā inenga i waenganui i te 5 me te 15 mg i hua ai 15 ki te 20.9 ōrau o te taumaha tinana i muri i te 72 wiki. Ahakoa i te 48 wiki, ka kitea e ngā kaiuru tētahi whakaheke taumaha tata ki te 14 ki te 19 ōrau. Kua kī etahi kaiwhakamahi i te ao tūturu kua ngaro atu i te 20 ōrau o tō rātou taumaha tinana.

Ko te whakamātau momona rangatira tuarua a Survodutide i whai atu ki te 387 kaiuru, ā, i whakaatu ai i te 6.2 ki te 14.9 ōrau o te whakaheke taumaha i ngā inenga teitei rawa atu i muri i te 46 wiki. Ko te hua teitei tata ki te 15 ōrau o te whakaheke taumaha he pai te titiro, engari he poto ake te rangahau, ā, he iti ake hoki i ngā whakamātau matua a te tirzepatide.

He mea nui kia mōhio ko te survodutide kei roto tonu i ngā whakamātau tuatoru. Ka taea e ngā rangahau nui ake, roa ake te whakaatu i ngā tau rereke. Engari i runga i tā tātou e mōhio ana i tēnei rā, kei te tino whakaputa te tirzepatide i te whakaheke taumaha nui ake i te katoa.

Ka pēhea te whakahaere huka toto?

He raraunga kaha tō Tirzepatide ki konei. I whakaatu ngā whakamātau haumanu i whakaiti ai i te HbA1c (he mehua o te huka toto toharite mō te toru marama) mā te 2.4 ōrau pūrua i roto i ngā tāngata whai mate huka momo 2. Ko tētahi o ngā whakaiti nui rawa atu i kitea i roto i tētahi rongoā mate huka werohanga.

Kua whakaatu hoki te Survodutide i ngā whakapainga o te taumata huka toto i runga i te inenga i roto i tana whakamātau mate huka tuarua. Heoi, he iti noa atu te huinga raraunga, ā, kei te whakapumautia tonu ngā hua i roto i ngā rangahau nui ake.

Mō ngā tāngata whai mate huka momo 2 e rapu ana i tētahi whiringa kua whakamātauhia i tēnei wā, kei te tirzepatide te turanga taunakitanga kaha ake.

Kei hea te painga o Survodutide?

Ko te painga ahurei o Survodutide ko tana mahi i te kaiwhiwhi glucagon, ā, ka taea e ia te hoatu painga kāore e whakaratohia e te tirzepatide.

Hauora ate. I roto i tētahi whakamātau tuarua o ngā tāngata whai MASH kua whakapumautia e te biopsy, me te fibrossi ate, 43 ki te 62 ōrau o ngā tāngata i rongoatia ki te survodutide i tutuki i te whāinga ate matua i muri i te 48 wiki, ka whakaritea ki te 14 ōrau ki te placebo. Mai i te 34 ki te 36 ōrau i whakaatu hoki i te iti rawa kotahi te taumata o te whakapainga fibrossi. Kua puta te tino hiahia mō ēnei hua i te mea he tino iti noa iho ngā rongoā whai mana mō te MASH i tēnei wā.

Te whakapau kaha. Ka taea e te ara glucagon te whakanui ake i te reiti pākawa okioki, arā, ka tahu ake ngā calories o tō tinana ahakoa kei te okioki. He huarahi rerekē tēnei mai i te tirzepatide, ka mahia matua mā te whakaiti i te nui o tō kai.

Kua whiwhi te Survodutide i ngā tohu Breakthrough Therapy me Fast Track a te FDA, e tohu ana ka kitea e ngā kaiwhakarite hei rongoā nui pea mō ngā mate kino. Kei te haere tonu te maha o ngā whakamātau tuatoru mō te momona me te MASH.

Me pēhea te whakarite o ngā pānga taha?

Ka hua nei ngā pānga taha ki te puku i roto i ngā rongoā e rua. He mea noa tēnei puta noa i te katoa o te akomanga o ngā rongoā mō te GLP-1.

Ki te tirzepatide, ko ngā pānga taha e tino korerohia ana ko te ruaki, te korere, te ruaki, me te kōpipiri. I roto i ngā whakamātau haumanu, tata ki te 4.3 ki te 7.1 ōrau o ngā kaiuru i mutu te rongoā nā te pānga taha. Ko te nuinga o ngā tohu ki te puku he māmā ki te ngawari, ā, ka kaha ki te whakapainga i te wā, ina koa ki te piki āta o ngā inenga.

Ki te survodutide, he rite tonu te tauira pānga taha: ruaki, korere, ruaki, me te kōpipiri. Heoi, i tētahi whakamātau mate huka tuarua, ko ngā mate ki te puku i korerohia e te 55 ōrau o ngā kaiuru survodutide ki te 22 ōrau ki te placebo. Ko ngā reiti whakamutunga nā te pānga taha te ahua nui ake i tō te tirzepatide, ahakoa kāore anō kia noho tētahi raraunga whakarite tika.

Ka hiahiatia e ngā rongoā e rua te pikinga āta o te inenga (tīmata āta me te piki āta) hei āwhina i tō tinana kia urutau, me te whakaiti i ngā tohu ki te puku.

Ko ēhea te mea e wātea ana i tēnei wā?

Kua whakaaetia e te FDA te Tirzepatide, ā, ka kitea mā te tohutohu. Ka tae mai i roto i ngā pene werohanga kua oti te takai, ka inengia ia wiki i te 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, me te 15 mg. Ka taea e te inihua te utu i raro i ngā whakaritenga motuhake mō te mate huka momo 2 me te whakahaere taumaha.

Kāore te Survodutide i te whakaaetia, kāore hoki e kitea i waho o ngā whakamātau haumanu. Kāore he wāhanga wā mō te whakaaetanga, i te mea kei te haere tonu ngā whakamātau tuatoru. Kāore e taea e koe te tiki mā te tohutohu, mā te rongoā i tēnei wā.

Te Pānga Whakamutunga

Ko te Tirzepatide he whiringa kua whakamātauhia, kua kitea hoki, me ngā raraunga kaha mō te whakaheke taumaha me te huka toto. Ko te Survodutide he rongoā rangahau whai take ka taea te hoatu painga ate me te metabolic ahurei mā tōna mahi glucagon. Mēnā e hiahiatia ana e koe tētahi rongoā i tēnei wā, ko te tirzepatide te whiringa mārama. Mēnā ka whakau ngā hua tuatoru o te survodutide tana kōrero tuatahi, ka taea e ia te noho hei whiringa nui a muri ake nei, ina koa mō ngā tāngata whai mate ate ngako.